Prednisone acetate

Phase 2Small molecule

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Prednisone acetate is one of 85 small molecule programs targeting Takayasu arteritis. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Takayasu ArteritisActive, not recruiting

Metastatic Prostate CancerActive, not recruiting

Prostate CancerActive, not recruiting

Takayasu ArteritisPreclinical

Active, not recruiting

Metastatic Prostate CancerPhase 2

Active, not recruiting

Prostate CancerPhase 1/Phase 2

Active, not recruiting

Competition

Competitive Landscape

1399 competitors in Prostate Cancer

#DrugCompanyPhaseTrials

Novantrone

Pfizer

Preclinical

5 2

Prednisone acetate

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 2

4 3

Mekinist

Novartis

Preclinical

3 4

Trexall

Alnylam Pharmaceuticals

Preclinical

—5

Jatenzo

GGrupo Espanol de Tumores Neuroendocrinos

Preclinical

2 6

Viagra

VViatris Specialty LLC

Preclinical

1 7

Prednisone/prednisolone

Roche

Preclinical

3 8

Triptorelin Pamoate

Ipsen

Preclinical

2 9

Therapeutic Hydrocortisone

EEastern Cooperative Oncology Group

Preclinical

9 10

Osmitrol

BB. Braun Medical Inc.

Preclinical

—

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2026

Phase 1/2Recruiting

Metastatic Prostate Cancer

NCT06689163

Q2 2027

Phase 1/2Recruiting

Prostate Cancer

NCT06568094

Q4 2030

Phase 3Recruiting

Prostate Cancer

NCT06136650

Clinical

Trials by Indication[1]

Prostate Cancer4 trials

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

Recruiting· Merck & Co. logo

Merck & Co.·Phase 3·NCT06136650·1,314 enrolled

A Study of HRS-5041 Tablets Combined With Antitumor Therapy in Subjects With Advanced Prostate Cancer

Recruiting·JJiangsu HengRui Medicine Co., Ltd.·Phase 1/2·NCT06568094·100 enrolled

Androgen Deprivation Therapy Combined With Docetaxel for High Risk Prostate Cancer

Unknown status·HHongqian Guo·Phase 2·NCT04869371·75 enrolled

Show 1 more trial

To Evaluate the Efficacy of TQB3823 Combined With Abiraterone and Prednisone in Metastatic Castration-resistant Prostate Cancer Patientsprednisone Acetate Tablets in Patients With Metastatic Castration-resistant Prostate Cancer

Terminated· Chia Tai Tianqing Pharmaceutical Group Co., Ltd. logo

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.·Phase 1/2·NCT05405439·39 enrolled

Metastatic Prostate Cancer2 trials

The Efficacy and Safety of Prostatectomy for Castration-Naive Oligometastatic Prostate Cancer

Completed·TThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School·Phase 2·NCT04992026·130 enrolled

A Study for the Treatment of Metastatic Prostate Cancer With HRS-1167 Tablets Combined With Abiraterone Acetate Tablets and Prednisone

Recruiting·JJiangsu HengRui Medicine Co., Ltd.·Phase 1/2·NCT06689163·66 enrolled

Treatment1 trial

Dextenza With ILUX for Treatment of MGD

Completed·WWarrenville Eyecare·Phase 4·NCT04658927·30 enrolled

Takayasu arteritis1 trial

Takayasu Arteritis Clinical Trial in China

Completed·JJiang lindi·N/A·NCT02981979·116 enrolled

Henoch-Schönlein Purpura1 trial

Study on Children Henoch-Schönlein Purpura Nephritis With TCM Multistep Treatment

Unknown status·HHenan University of Traditional Chinese Medicine·Phase 1/2·NCT03591471·500 enrolled

Sources

References

[1]
ClinicalTrials.gov — 9 trial records for Prednisone acetate. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Prednisone acetate compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Prednisone acetate. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Chia Tai Tianqing Pharmaceutical Group Co., Ltd. company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Prednisone acetate

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2026

Q2 2027

Q4 2030

Trials by Indication[1]

Prostate Cancer4 trials

Metastatic Prostate Cancer2 trials

Treatment1 trial

Takayasu arteritis1 trial

Henoch-Schönlein Purpura1 trial

References

Drug Info

Quick Facts

Related News